We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Virotec Intl | LSE:VTI | London | Ordinary Share | GB00B15PVR02 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 3340X Virotec International PLC 23 June 2008 Virotec International plc ("Virotec") 23 June 2008 Acquisition of Virotec by Hydrodec Group plc: Court Hearing to sanction Scheme and to confirm Reduction of Capital The order sanctioning the Scheme and confirming the Reduction was granted at the Court Hearing held earlier today and is expected to become effective from 24 June 2008. Accordingly, trading in Virotec shares have been suspended and it is expected that the Virotec Shares on AIM will be cancelled from 7.00am on 25 June 2008. The New Hydrodec Shares due to Virotec shareholders will be allotted today. Dealings in the New Hydrodec Shares are expected to commence at 8.00am on 25 June 2008. Fractional entitlements to New Hydrodec Shares will be retained and sold in the market for the benefit of the Enlarged Group. Cheques for those Virotec Shareholders who will receive cash as full or part settlement will be sent no later than 14 days after the Effective Date. Unless the context otherwise requires, capitalised terms used, but not defined, in this announcement have the same meanings as given to them in the Scheme Document dated 13 May 2008. Enquiries: Virotec International plc Angus Craig Tel: + 61 7 5573 3353 Arden Partners plc Christopher Hardie / Matthew Armitt Tel: +44 (0)20 7398 1600 Arden Partners plc, which is regulated in the United Kingdom by the Financial Services Authority, is acting for Virotec and no-one else in connection with the Acquisition and Disposal (as defined in the Scheme Document) and will not be responsible to anyone other than Virotec for providing the protections afforded to customers of Arden or for providing advice in relation to the Acquisition and Disposal or any other matter referred to in this announcement. This information is provided by RNS The company news service from the London Stock Exchange END MSCFJMATMMTTBFP
1 Year Virotec Chart |
1 Month Virotec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions